SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Joe who wrote (1950)1/5/1999 4:17:00 PM
From: Bruce L  Read Replies (1) | Respond to of 4140
 
Joe: Excellent piece you've done on KERA: thorough, complete and VERY topical for SNRS.

Thanks,

lBruce



To: Joe who wrote (1950)1/6/1999 1:04:00 AM
From: Joe  Read Replies (2) | Respond to of 4140
 
p.s. Re: KERA

While it is instructive to look at KERA to see how investors react to the activity with FDA, I do not think very much of their approach to correction of vision. How can an approach as invasive as an implant in the cornea be made acceptable to the patient when compared to PRK or LASIK. But, then again, how can LASIK be an acceptable approach from the patients perspective when an improved PRK is available?

Joe


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News